PPARG and early-onset autosomal dominant Alzheimer disease: Through PPARγ modulation, this neolignan exerts anti-inflammatory actions in animal models of acute lung injury [198], ulcerative colitis [199], and Alzheimer’s disease [200], as well as cardioprotective effects [201,202], and beneficial properties in metabolic disorders [203].